Stryker | SYK - Gewinn Vor Steuern

Aktienkurs
314.95
Täglich Wechseln
-6.54 -2.03%
Monatlich
-3.77%
Jährlich
-17.06%
Q2 Prognose
300.59




Gewinn Vor Steuern Veränderung Datum
Abbott USD 2.39B 27M 2026-03
AtriCure USD 394K 1.97M 2026-03
Avanos Medical USD 1.2M 2.4M 2025-12
Baxter International USD -756M 877M 2025-12
Becton, Dickinson and Co. USD 393M 117M 2025-12
Boston Scientific USD 700M 238M 2025-12
CONMED USD 29.25M 24.98M 2025-12
Cooper Companies USD 116.8M 137.4M 2025-09
Danaher USD 1.24B 138M 2026-03
Dexcom USD 340.7M 40.7M 2025-12
Edwards Lifesciences USD 348.4M 51.8M 2025-09
Globus Medical USD 169.23M 25.24M 2025-12
Haemonetics USD 59.97M 8.69M 2025-12
Insulet USD 113M 27.2M 2026-03
Integra LifeSciences USD -2.41M 6.72M 2026-03
Intuitive Surgical USD 955.6M 100.4M 2025-12
J&J USD 7.82B 2.86B 2026-03
Masimo USD 71.3M 3.6M 2026-03
Medtronic USD 2.1B 224M 2025-09
Merit Medical Systems USD 51.06M 22.12M 2025-12
Olympus JPY 27.08B 4.95B 2026-03
Smith & Nephew USD 469M 70M 2025-12
Steris USD 257.8M 66.6M 2025-12
Stryker USD 1.7B 676M 2025-12
Tandem Diabetes Care USD 4.68M 29.82M 2025-12
Teleflex USD 218.94M 657.52M 2025-12
Terumo JPY 31.67B 13.71B 2026-03
Zimmer Biomet Holdings USD 98M 320.7M 2025-12